A new study looks at how a gene associated with bipolar disorder affects the balance between inhibition and excitation; revealing a link with epilepsy.
Researchers use new approach to identify genetic components of bipolar disorder.
A landmark new study identified ten genes with rare protein disrupting mutations that significantly increase the risk of a person developing schizophrenia.
2018 is almost upon us. We thought it would be a good time to take a look back at some of the most popular Neuroscience News stories of 2017.
Dialectical behavior therapy (DBT) appears to be a feasible and acceptable therapy to help with mood regulation in those with bipolar disorder.
Researchers have identified a range of psychiatric disorders, including schizophrenia and autism, that share physical characteristics at the molecular level. Specifically, the study identifies common patterns of neural gene expression. In addition, researchers note important differences in gene expression that distinguish the disorders.
According to researchers, fMRI brain scans may be used to predict a patient's responsiveness to antipsychotic medications.
Patients with mood and anxiety disorders have abnormally low activation in brain areas associated with cognitive and emotional control. Brain scans also revealed hyperactivity in brain areas linked to the processing of emotional thoughts.
People with bipolar disorder have higher incidences of Parkinson's disease than those without the psychiatric condition. Manic and depressive episodes were associated with an elevated risk of developing Parkinson's disease.
The largest delay discounting effects were found to be associated with bipolar disorder, borderline personality disorder, and schizophrenia. The image is in the public domain.
